Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

20.48 

-0.60 -2.9%

as of Mar 25 '19

52 Week Range:

16.54 29.79


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; and VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges, as well as operates as an original equipment manufacturer of custom reagents and instrumentation. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 3.24
3.36
4.21
4.74
4.59
4.58
5.80
7.40
8.90
8.46
9.19
growth rate 3.7% 25.3% 12.6% -3.2% -0.2% 26.6% 27.6% 20.3% -4.9% 8.6%
Earnings BIT 31.22
37.36
26.67
37.15
30.55
growth rate 19.7% -28.6% 39.3% -17.8%
Avg.PE 52.67
54.45
23.09
50.56
growth rate 3.4% -57.6% 119.0%
ROA 1.79
7.62
2.04
5.28
4.28
2.35
11.77
9.70
3.24
6.14
3.58
growth rate 325.7% -73.2% 158.8% -18.9% -45.1% 400.9% -17.6% -66.6% 89.5% -41.7%
ROE 2.05
8.58
2.31
5.96
4.86
2.68
13.24
10.71
3.58
6.87
4.02
growth rate 318.5% -73.1% 158.0% -18.5% -44.9% 394.0% -19.1% -66.6% 91.9% -41.5%
ROIC 2.31
8.57
2.38
5.94
4.84
2.68
13.25
10.71
3.58
6.87
4.02
growth rate 271.0% -72.2% 149.6% -18.5% -44.6% 394.4% -19.2% -66.6% 91.9% -41.5%
Cur. Ratio 9.84
7.19
8.68
7.21
4.71
5.14
5.83
7.69
4.32
4.96
3.95
growth rate -26.9% 20.7% -16.9% -34.7% 9.1% 13.4% 31.9% -43.8% 14.8% -20.4%
Quick Ratio 8.95
6.15
7.02
5.62
3.25
3.63
3.98
6.22
3.13
3.71
2.53
growth rate -31.3% 14.2% -19.9% -42.2% 11.7% 9.6% 56.3% -49.7% 18.5% -31.8%
Leverage 1.12
1.13
1.13
1.13
1.14
1.14
1.12
1.09
1.12
1.12
1.12
growth rate 0.9% 0.0% 0.0% 0.9% 0.0% -1.8% -2.7% 2.8% 0.0% 0.0%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 28.27
28.85
32.37
40.65
53.40
growth rate 2.1% 12.2% 25.6% 31.4%
Acct.Payable 11.84
7.87
12.28
14.54
14.50
growth rate -33.6% 56.0% 18.4% -0.2%
Cur.Assets 177.02
209.53
173.74
224.64
202.74
growth rate 18.4% -17.1% 29.3% -9.8%
Total Assets 357.53
402.56
450.72
490.52
525.18
growth rate 12.6% 12.0% 8.8% 7.1%
Cash 91.69
128.55
93.45
127.11
76.44
growth rate 40.2% -27.3% 36.0% -39.9%
Inventory 36.62
31.25
40.78
49.48
63.25
growth rate -14.7% 30.5% 21.3% 27.8%
Cur.Liabilities 30.37
27.23
40.20
45.25
51.38
growth rate -10.3% 47.6% 12.6% 13.5%
Liabilities 37.53
34.02
47.04
52.61
57.52
growth rate -9.4% 38.3% 11.9% 9.3%
Equity 319.99
368.54
403.68
437.91
467.66
growth rate 15.2% 9.5% 8.5% 6.8%
Common Shares 40.00
42.00
42.00
43.00
42.00
42.00
42.00
43.00
43.00
43.00
44.00
growth rate 5.0% 0.0% 2.4% -2.3% 0.0% 0.0% 2.4% 0.0% 0.0% 2.3%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 17.08
18.71
13.13
14.64
21.29
growth rate 9.5% -29.8% 11.5% 45.5%
Cash Dividends 7.93
7.93
7.93
7.93
10.65
growth rate 0.0% 0.0% 0.0% 34.4%
Cash From OA 51.34
57.38
49.68
57.43
50.90
growth rate 11.8% -13.4% 15.6% -11.4%
FCF per Share 0.35
-0.09
0.18
0.49
0.22
0.14
0.54
0.80
0.78
0.64
0.94
growth rate -100.0% 100.0% 172.2% -55.1% -36.4% 285.7% 48.2% -2.5% -18.0% 46.9%
Sale Purchase of Stock 4.75
3.12
5.09
4.31
growth rate -34.3% 63.2% -15.4%
FCF 8.00
-5.00
11.00
27.00
13.00
8.00
32.00
36.00
36.00
43.00
26.00
growth rate -100.0% 100.0% 145.5% -51.9% -38.5% 300.0% 12.5% 0.0% 19.4% -39.5%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 226.98
237.71
270.64
306.57
315.82
growth rate 4.7% 13.9% 13.3% 3.0%
Op.Income 31.22
37.36
26.67
37.15
30.55
growth rate 19.7% -28.6% 39.3% -17.8%
IBT 28.09
33.04
19.62
37.15
28.31
growth rate 17.7% -40.6% 89.4% -23.8%
Net Income 39.04
36.86
13.81
29.42
18.51
growth rate -5.6% -62.5% 113.0% -37.1%
EPS 0.08
0.43
0.12
0.34
0.30
0.17
0.93
0.86
0.32
0.67
0.41
growth rate 437.5% -72.1% 183.3% -11.8% -43.3% 447.1% -7.5% -62.8% 109.4% -38.8%
Gross Profit 161.05
168.71
179.86
199.05
195.49
growth rate 4.8% 6.6% 10.7% -1.8%
R&D 43.14
42.69
48.66
45.72
47.16
growth rate -1.0% 14.0% -6.1% 3.2%

Quarterly Statements

Item Name Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Earnings BIT 9.13
15.27
7.86
3.75
3.67
growth rate 67.2% -48.5% -52.2% -2.3%
Balance Sheet Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Acct.Receivable 40.65
46.28
46.78
42.21
53.40
growth rate 13.9% 1.1% -9.8% 26.5%
Acct.Payable 14.54
14.71
12.60
13.30
14.50
growth rate 1.2% -14.3% 5.6% 9.1%
Cur.Assets 224.64
234.88
245.84
256.05
202.74
growth rate 4.6% 4.7% 4.2% -20.8%
Total Assets 490.52
500.51
510.23
515.83
525.18
growth rate 2.0% 1.9% 1.1% 1.8%
Cash 127.11
128.66
139.00
146.89
76.44
growth rate 1.2% 8.0% 5.7% -48.0%
Inventory 49.48
52.25
52.09
55.05
63.25
growth rate 5.6% -0.3% 5.7% 14.9%
Cur.Liabilities 45.25
35.13
36.38
38.78
51.38
growth rate -22.4% 3.6% 6.6% 32.5%
Liabilities 52.61
43.51
44.70
47.62
57.52
growth rate -17.3% 2.7% 6.5% 20.8%
Equity 437.91
457.01
465.53
468.21
467.66
growth rate 4.4% 1.9% 0.6% -0.1%
Common Shares 0.04
0.04
0.04
0.04
0.04
growth rate 2.3% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Capital Expenditures 4.25
4.07
4.97
5.23
7.03
growth rate -4.3% 22.1% 5.2% 34.4%
Cash Dividends 2.65
2.62
2.68
2.68
2.68
growth rate -0.9% 2.1% -0.1% 0.0%
Cash From OA 23.07
13.96
17.50
15.15
4.29
growth rate -39.5% 25.4% -13.4% -71.7%
Sale Purchase of Stock 1.07
1.13
2.29
growth rate 5.0% 103.4%
FCF 18.82
9.89
12.53
9.92
-2.74
growth rate -47.5% 26.7% -20.8% -100.0%
Income Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Sales 78.20
82.66
79.58
72.45
81.13
growth rate 5.7% -3.7% -9.0% 12.0%
Op.Income 9.13
15.27
7.86
3.75
3.67
growth rate 67.2% -48.5% -52.2% -2.3%
IBT 9.13
15.72
7.87
3.76
0.97
growth rate 72.1% -50.0% -52.2% -74.3%
Net Income -2.97
13.40
5.67
1.74
-2.30
growth rate 100.0% -57.7% -69.4% -100.0%
Gross Profit 50.38
53.59
49.31
44.26
48.34
growth rate 6.4% -8.0% -10.2% 9.2%
R&D 10.37
10.33
11.67
12.00
13.17
growth rate -0.4% 13.0% 2.8% 9.8%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (29.84)

YOY Growth Grade:

D (33.94)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 51.29 49.83
EPS / Growth 0.41

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 8.2%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 8.2% 8.2% 8.2%
Future PE 0.01 8.17 8.17
Future EPS 0.90 0.90 0.90
Value Price
MOS %
0.00
-100.0%
1.82
-91.1%
1.82
-91.1%
MOS Price 0.00 0.91 0.91
IRT 19.88 19.88 19.88

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.